Pulmuone reported that its consolidated operating profit for the second quarter of this year reached 19.6 billion won, according to a disclosure on the 14th. This is a 16.1% increase compared to the same period last year.
According to the Financial Supervisory Service electronic disclosure system, Pulmuone's consolidated sales for the second quarter of this year are 839.1 billion won. This marks a 5.8% increase compared to the same period last year. For the first half of the year, sales reached 1.6326 trillion won, an increase of 4.5% compared to the same period last year. During the same period, operating profit was 30.8 billion won, a decrease of 5.2% compared to the same period last year.
The domestic food manufacturing and distribution sector saw a 6.2% increase in sales compared to the previous year, driven by the effects of new product launches in B2C (business-to-consumer) transactions. Operating profit also rose by 87.1%. The food service distribution sector experienced a 9.5% increase in overall sales compared to the previous year, fueled by growth in large business sites and group catering, as well as increased revenue from airport lounges.
The overseas food manufacturing and distribution sector saw a 29.6% growth in sales compared to the previous year due to the successful launch of new products like frozen gimbap and shelf-stable pasta in its Chinese subsidiary. However, the U.S. subsidiary faced limitations on overall growth due to local conditions, resulting in a 0.9% decrease in total revenue and a slight expansion of losses.
A Pulmuone official noted, 'In the second half, the domestic food manufacturing and distribution sector will continue to launch innovative new products in categories such as tofu, shelf-stable and HMR (home meal replacement), and the Earth food plan.' He added, 'The overseas food manufacturing and distribution sector plans to improve overall sales and operating profit through the expansion of tofu channels in the U.S. subsidiary and continuous launches of shelf-stable and frozen new products in the Chinese subsidiary.'